文献速递临床试验与 GCP真实世界研究与卫生经济

Live Well with Parkinson's自管理干预与常规治疗对帕金森病患者生活质量改善的临床与成本效果:随机对照试验研究方案

Clinical and cost-effectiveness of 'Live Well with Parkinson's' self-management intervention versus treatment as usual for improving quality of life for people with Parkinson's: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2023-12-05

本研究为单盲两臂随机对照试验,评估由非专科支持者提供最多6次会话的Live Well with Parkinson's自管理工具包(数字版与纸质版)对帕金森病患者生活质量的临床效果与成本效果。计划从英格兰多地招募338名帕金森病患者及其照护者,主要结局为12个月时帕金森病问卷(PDQ-39)评分,并设6个月和12个月随访。

要点

  • 工具包基于理论行为改变与自管理技术,与患者及健康和社会照护从业者协商开发。
  • 主要结局为12个月时PDQ-39评分,评估者设盲。
  • 计划招募338名帕金森病患者,排除晚期痴呆、终末期或非典型帕金森综合征者。

核心结论

  • 若试验成功,Live Well with Parkinson's工具包可作为其他复杂长期疾病(包括痴呆)的模型,弥补NHS现有缺口。

研究设计与样本

  • 单盲两臂随机对照试验,评估工具包在改善生活质量方面的临床效果与成本效果,由受过培训的非专科支持者提供最多6次会话。
  • 计划从英格兰多样化的环境中招募338名帕金森病患者及其照护者(如适用)。
  • 在基线、6个月和12个月进行评估,评估者对治疗分组设盲。

主要发现

  • 主要结局指标为12个月时帕金森病问卷(PDQ-39,帕金森病相关生活质量)评分。
  • 次要结局指标包括MDS统一帕金森病评定量表(第I、II、III、IV部分)、EQ-5D以及为帕金森病缩短改编的客户服务接收清单。
  • 照护者结局包括Zarit照护者负担量表和帕金森综合征照护者生活质量问卷。
  • 将开展平行混合方法过程评估,探讨促进或抑制工具包及会话实施、采纳、使用、效果和成本效果的因素。

关键数值与推荐

  • 排除标准包括晚期痴呆、终末期或非典型帕金森综合征。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Live Well with Parkinson's Self-Management Toolkit is designed for use in the NHS to support people with Parkinson's, their carers and health professionals in managing motor and non-motor symptoms and promoting well-being. The Toolkit was developed based on theory-based behaviour change and self-management techniques in consultation with people living with Parkinson's and health and social care practitioners. There are digital (e-Toolkit) and paper (manual) versions. METHODS: Single-blind two-arm randomised controlled trial RCT of clinical effectiveness and cost-effectiveness of the Toolkit, facilitated by up to six sessions with a trained non-specialist supporter, in improving quality of life. People with Parkinson's will be assessed at baseline, 6 and 12 months. Assessors will be blind to the treatment group. The primary outcome measure is the Parkinson's Disease Questionnaire (PDQ-39, Parkinson's related quality of life) score at 12 months. Secondary outcome measures include the MDS Unified Parkinson's Disease Rating Scale (Part I, II, III, IV), EQ-5D, and a Client Service Receipt Inventory shortened, adapted for Parkinson's. Carer outcomes include the Zarit Carer Burden Inventory and Carer Quality of Life Questionnaire for Parkinsonism. A total of 338 people with Parkinson's, and their carers if appropriate, will be recruited from diverse settings across England. Those with advanced dementia, at end-of-life or with atypical Parkinsonism will be excluded. A parallel mixed methods process evaluation will explore the factors promoting or inhibiting implementation, uptake, use, effectiveness and cost-effectiveness of the Toolkit and sessions. DISCUSSION: If successful, the Live Well with Parkinson's Toolkit could be used as a model for other complex long-term disorders, including dementia. This would bridge existing gaps in the NHS (as shown by the national Parkinson's audit data), by enabling patients and carers to access personalised information, advice and support on symptom management and 'living well' with Parkinson's. TRIAL REGISTRATION: ISRCTN92831552. Registered on 26th Oct 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Walters K, Armstrong M, Gardner B, et al. Clinical and cost-effectiveness of 'Live Well with Parkinson's' self-management intervention versus treatment as usual for improving quality of life for people with Parkinson's: study protocol for a randomised controlled trial. Trials. 2023. PMID: 38053209. doi:10.1186/s13063-023-07700-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。